InspireMD (InspireMD) Net Margin %

: -306.93% (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. InspireMD's Net Income for the three months ended in Dec. 2023 was $-5.41 Mil. InspireMD's Revenue for the three months ended in Dec. 2023 was $1.76 Mil. Therefore, InspireMD's net margin for the quarter that ended in Dec. 2023 was -306.93%.

The historical rank and industry rank for InspireMD's Net Margin % or its related term are showing as below:

NSPR' s Net Margin % Range Over the Past 10 Years
Min: -890.53 Med: -344.74 Max: -201.06
Current: -320.97

NSPR's Net Margin % is ranked worse than
85.57% of 818 companies
in the Medical Devices & Instruments industry
Industry Median: 0.045 vs NSPR: -320.97

InspireMD Net Margin % Historical Data

The historical data trend for InspireMD's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

-269.82

-424.31

-331.88

-357.59

-320.97

InspireMD Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Margin %																-472.22	-343.50	-307.88	-332.78	-306.93

Competitive Comparison

For the Medical Devices subindustry, InspireMD's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD Net Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Net Margin % distribution charts can be found below:

* The bar in red indicates where InspireMD's Net Margin % falls into.

InspireMD Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

InspireMD's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-19.916	/	6.205
	=	-320.97 %

InspireMD's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-5.405	/	1.761
	=	-306.93 %

InspireMD (NAS:NSPR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

InspireMD Net Margin % Related Terms

Thank you for viewing the detailed overview of InspireMD's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

InspireMD (InspireMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (NAS:NSPR) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832

Website

https://www.inspiremd.com

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

Executives

Gary S Roubin	director	4300 ROCKMORE RD JACKSON, WYOMING WY 83001
Patrick Verta	officer: EVP Clinical/Medical Affairs	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Berman	director	735 PALAMAR AVENUE, SUNNYVALE CA 94085
Thomas J Kester	director	C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Paul Stuka	director	C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
Andrea Tommasoli	officer: Chief Operating Officer	22, RUE DE LA PLAGE, COLLONGES AU MONT D OR I0 69660
Shane Thomas Gleason	officer: VP Global Marketing	18 NORTHAMPTON PL, COTO DE CAZA CA 92679
Kathryn Arnold	director	1136 CHESTNUT AVE., WILMETTE IL 60091
Marvin Slosman	director, officer: CEO and President	4 MENORAT HAMAOR ST., C/O INSPIREMD, INC., TEL AVIV L3 6744832
Isaac Blech	director	C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Agustin V Gago	officer: EVP, Chief Commercial Officer	256 JERUSALEM AVE, MASSAPEQUA NY 11758
Eric L. Olson	officer: VP of Global Sales Operations	C/O INSPIREMD, INC., 800 BOYLSTON STREET, 16TH FLOOR, BOSTON MA 02199
Campbell Rogers	director	C/O INSPIREMD, INC., 800 BOYLSTON STREET, SUITE 16041, BOSTON MA 02199
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Eyal Weinstein	director	C/O LEOREX LTD., P.O.B. 15067 MATAM, HAIFA L3 31905